Wellgistics Health Inc. (WGRX) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Wellgistics Health Inc.

    NASDAQ: WGRX · Real-Time Price · USD
    0.68
    -0.12 (-15.13%)
    At close: Oct 03, 2025, 3:59 PM
    0.69
    1.71%
    After-hours: Oct 03, 2025, 07:58 PM EDT

    Wellgistics Health Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
    Revenue
    		 18.41M 21.05M 18.13M 68.55M 52.75M 42.31M 34.37M n/a n/a
    Cost of Revenue
    		 17.66M 19.41M 16.36M 62.81M 47.76M 38.72M 31.6M n/a n/a
    Gross Profit
    		 746.4K 1.64M 1.77M 5.74M 4.99M 3.59M 2.77M n/a n/a
    Operating Income
    		 -39.22M -36.01M -6.15M -16.99M -14.99M -13.13M -11.65M -1.33M -428.76K
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 -41.8M -37.51M -6.86M -19.01M -16.86M -14.9M -13.13M -1.33M -428.76K
    Net Income
    		 -41.8M -37.51M -6.86M -19.01M -16.86M -14.9M -13.13M -1.33M -428.76K
    Selling & General & Admin
    		 39.57M 36.2M 6.8M 14.43M 12.87M 11.47M 9.63M 1.33M 428.76K
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 399.9K 1.45M 1.11M 8.3M 7.11M 5.26M 4.79M n/a n/a
    Operating Expenses
    		 39.97M 37.65M 7.91M 22.73M 19.98M 16.73M 14.42M 1.33M 428.76K
    Interest Expense
    		 2.29M 1.63M 831.47K 2.75M 2.4M 1.88M 1.58M n/a n/a
    Selling & Marketing Expenses
    		 408.6K 65.22K n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 57.63M 57.06M 24.27M 85.54M 65.93M 52.78M 43.36M -1.33M -428.76K
    Income Tax Expense
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 61.77M 51.92M 51.94M 51.94M 51.94M 48.86M 46.79M 51.94M 51.94M
    Shares Outstanding (Diluted)
    		 61.77M 51.92M 51.94M 51.94M 51.94M 48.86M 46.79M 51.94M 51.94M
    EPS (Basic)
    		 -0.85 -0.75 -0.17 -0.34 -0.32 -0.31 -0.28 -0.03 -0.01
    EPS (Diluted)
    		 -0.85 -0.75 -0.17 -0.34 -0.32 -0.31 -0.28 -0.03 -0.01
    EBITDA
    		 -36.07M -31.39M -1.87M -7.95M -7.35M -7.77M -6.76M -1.33M -428.76K
    EBIT
    		 -39.51M -35.89M -6.02M -16.26M -14.46M -13.03M -11.55M -1.33M -428.76K
    Depreciation & Amortization
    		 3.44M 4.49M 4.16M 8.3M 7.11M 5.26M 4.79M n/a n/a

    Add to Watchlist